已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Low dialysate sodium levels for chronic haemodialysis

血液透析 医学 内科学 重症监护医学 材料科学 冶金
作者
Joanna Dunlop,Alain C. Vandal,Mark R. Marshall
出处
期刊:The Cochrane library [Elsevier]
被引量:51
标识
DOI:10.1002/14651858.cd011204.pub2
摘要

Background Cardiovascular (CV) disease is the leading cause of death in dialysis patients, and strongly associated with fluid overload and hypertension. It is plausible that low dialysate [Na+] may decrease total body sodium content, thereby reducing fluid overload and hypertension, and ultimately reducing CV morbidity and mortality. Objectives This review evaluated harms and benefits of using a low (< 138 mM) dialysate [Na+] for maintenance haemodialysis (HD) patients. Search methods We searched the Cochrane Kidney and Transplant Register of Studies up to 7 August 2018 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. Selection criteria Randomised controlled trials (RCTs), both parallel and cross‐over, of low (< 138 mM) versus neutral (138 to 140 mM) or high (> 140 mM) dialysate [Na+] for maintenance HD patients were included. Data collection and analysis Two investigators independently screened studies for inclusion and extracted data. Statistical analyses were performed using random effects models, and results expressed as risk ratios (RR) for dichotomous outcomes, and mean differences (MD) or standardised MD (SMD) for continuous outcomes, with 95% confidence intervals (CI). Confidence in the evidence was assessed using GRADE. Main results We included 12 studies randomising 310 patients, with data available for 266 patients after dropout. All but one study evaluated a fixed concentration of low dialysate [Na+], and one profiled dialysate [Na+]. Three studies were parallel group, and the remaining nine cross‐over. Of the latter, only two used a washout between intervention and control periods. Most studies were short‐term with a median (interquartile range) follow‐up of 3 (3, 8.5) weeks. Two were of a single HD session, and two of a single week's HD. Half of the studies were conducted prior to 2000, and five reported use of obsolete HD practices. Risks of bias in the included studies were often high or unclear, lowering confidence in the results. Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "efficacy" endpoints: reduced interdialytic weight gain (10 studies: MD ‐0.35 kg, 95% CI ‐0.18 to ‐0.51; high certainty evidence); probably reduced predialysis mean arterial blood pressure (BP) (4 studies: MD ‐3.58 mmHg, 95% CI ‐5.46 to ‐1.69; moderate certainty evidence); probably reduced postdialysis mean arterial BP (MAP) (4 studies: MD ‐3.26 mmHg, 95% CI ‐1.70 to ‐4.82; moderate certainty evidence); probably reduced predialysis serum [Na+] (7 studies: MD ‐1.69 mM, 95% CI ‐2.36 to ‐1.02; moderate certainty evidence); may have reduced antihypertensive medication (2 studies: SMD ‐0.67 SD, 95% CI ‐1.07 to ‐0.28; low certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "safety" endpoints: probably increased intradialytic hypotension events (9 studies: RR 1.56, 95% 1.17 to 2.07; moderate certainty evidence); probably increased intradialytic cramps (6 studies: RR 1.77, 95% 1.15 to 2.73; moderate certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] may make little or no difference to: intradialytic BP (2 studies: MD for systolic BP ‐3.99 mmHg, 95% CI ‐17.96 to 9.99; diastolic BP 1.33 mmHg, 95% CI ‐6.29 to 8.95; low certainty evidence); interdialytic BP (2 studies:, MD for systolic BP 0.17 mmHg, 95% CI ‐5.42 to 5.08; diastolic BP ‐2.00 mmHg, 95% CI ‐4.84 to 0.84; low certainty evidence); dietary salt intake (2 studies: MD ‐0.21g/d, 95% CI ‐0.48 to 0.06; low certainty evidence). Due to very low quality of evidence, it is uncertain whether low dialysate [Na+] changed extracellular fluid status, venous tone, arterial vascular resistance, left ventricular mass or volumes, thirst or fatigue. Studies did not examine cardiovascular or all‐cause mortality, cardiovascular events, or hospitalisation. Authors' conclusions It is likely that low dialysate [Na+] reduces intradialytic weight gain and BP, which are effects directionally associated with improved outcomes. However, the intervention probably also increases intradialytic hypotension and reduces serum [Na+], effects that are associated with increased mortality risk. The effect of the intervention on overall patient health and well‐being is unknown. Further evidence is needed in the form of longer‐term studies in contemporary settings, evaluating end‐organ effects in small‐scale mechanistic studies using optimal methods, and clinical outcomes in large‐scale multicentre RCTs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
激情的白枫完成签到 ,获得积分10
1秒前
kannar完成签到,获得积分10
1秒前
车厘子完成签到 ,获得积分10
1秒前
BBH发布了新的文献求助10
2秒前
yema完成签到 ,获得积分10
3秒前
迷人的天抒应助竹萧采纳,获得10
3秒前
LC完成签到 ,获得积分10
4秒前
十二关注了科研通微信公众号
4秒前
5秒前
zly完成签到 ,获得积分10
6秒前
哈哈哈哈发布了新的文献求助10
7秒前
11秒前
11秒前
12秒前
纯真衬衫发布了新的文献求助10
15秒前
科目三应助李世航采纳,获得30
15秒前
李爱国应助Sugar采纳,获得10
16秒前
芯之痕发布了新的文献求助30
16秒前
wenzheng完成签到 ,获得积分10
17秒前
哈哈完成签到 ,获得积分10
18秒前
钟基基完成签到 ,获得积分10
20秒前
若什么至完成签到,获得积分10
22秒前
23秒前
小全完成签到,获得积分10
24秒前
lijunliang完成签到 ,获得积分10
29秒前
一颗小草发布了新的文献求助10
29秒前
29秒前
传奇3应助znlion采纳,获得10
32秒前
FashionBoy应助1356采纳,获得30
32秒前
十二发布了新的文献求助10
36秒前
研友_VZG7GZ应助无限的书芹采纳,获得10
37秒前
丘比特应助hlink采纳,获得10
37秒前
田様应助三水采纳,获得10
38秒前
沐沐溪三清完成签到 ,获得积分10
38秒前
39秒前
可爱的函函应助木讷山采纳,获得10
43秒前
Sugar发布了新的文献求助10
44秒前
医学小王完成签到 ,获得积分10
44秒前
土豪的灵竹完成签到 ,获得积分10
46秒前
科研通AI5应助Trends采纳,获得10
47秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976572
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204365
捐赠科研通 3257284
什么是DOI,文献DOI怎么找? 1798667
邀请新用户注册赠送积分活动 877835
科研通“疑难数据库(出版商)”最低求助积分说明 806577